Completely agree. To see it being used in extremely complex scenarios with immunosuppressed patients battling severe infection and having great wound recovery outcomes is phenomenal. Throw a biological into that mess and you would have a soup for infection to thrive in. This is groundbreaking.
- Forums
- ASX - By Stock
- PNV
- PNV Media Thread
PNV Media Thread, page-897
-
- There are more pages in this discussion • 2,318 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.33 |
Change
0.060(2.64%) |
Mkt cap ! $1.615B |
Open | High | Low | Value | Volume |
$2.33 | $2.38 | $2.29 | $1.529M | 654.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 11225 | $2.33 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.34 | 32317 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 11825 | 2.350 |
26 | 73076 | 2.340 |
14 | 23939 | 2.330 |
15 | 66057 | 2.320 |
9 | 18436 | 2.310 |
Price($) | Vol. | No. |
---|---|---|
2.360 | 25213 | 29 |
2.370 | 27500 | 17 |
2.380 | 33172 | 14 |
2.390 | 62176 | 12 |
2.400 | 137265 | 13 |
Last trade - 11.37am 26/06/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |